GOLDMAN SACHS GROUP INC - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$2,507,820
+253.4%
212,888
+255.8%
0.00%
Q1 2024$709,595
-82.5%
59,831
-81.9%
0.00%
-100.0%
Q4 2023$4,051,063
+101.5%
330,699
+58.4%
0.00%
Q3 2023$2,010,860
-23.8%
208,812
-28.8%
0.00%
-100.0%
Q2 2023$2,639,799
+21.9%
293,311
+6.5%
0.00%
Q1 2023$2,165,304
-7.3%
275,484
-20.3%
0.00%
-100.0%
Q4 2022$2,336,966
+47525.1%
345,705
+2.2%
0.00%0.0%
Q3 2022$4,907
+65.5%
338,180
+12.2%
0.00%0.0%
Q2 2022$2,965
-99.9%
301,275
+80.7%
0.00%0.0%
Q1 2022$2,457,000
+86.8%
166,705
+67.7%
0.00%
Q4 2021$1,315,000
+8.7%
99,431
+43.5%
0.00%
Q3 2021$1,210,000
+59.8%
69,295
+119.2%
0.00%
Q2 2021$757,000
-46.0%
31,610
-42.1%
0.00%
Q1 2021$1,403,000
+598.0%
54,599
+416.5%
0.00%
Q4 2020$201,000
-54.8%
10,570
-71.3%
0.00%
Q2 2020$445,000
+23.6%
36,781
+82.0%
0.00%
Q4 2019$360,000
-34.1%
20,213
-57.1%
0.00%
Q3 2019$546,000
+17.9%
47,094
+125.2%
0.00%
Q2 2019$463,000
-57.2%
20,913
-44.7%
0.00%
Q1 2019$1,082,000
+616.6%
37,790
+143.4%
0.00%
Q4 2017$151,00015,5280.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 2,579,490$20,146,00022.25%
Novo Holdings A/S 2,901,927$22,664,0002.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 322,436$2,518,0000.96%
Vivo Capital, LLC 300,325$2,346,0000.69%
VHCP Management II, LLC 221,651$1,635,0000.67%
RA Capital Management 591,070$4,616,0000.57%
INTERWEST VENTURE MANAGEMENT CO 329,942$2,577,0000.55%
Eventide Asset Management 98,100$766,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 21,665$169,0000.03%
A.R.T. Advisors, LLC 11,116$86,0000.00%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders